Dexcom | DXCM - Ebitda



金融业
股票价格
USD 79.41
资产
USD 6.24B
现金及等价物
USD 961.4M
销售成本
USD 478.4M
流动资产
USD 3.92B
流动负债
USD 2.25B
债务
USD 1.24B
EBIT
USD 318.3M
EBITDA
USD 435.2M
员工
10.3K
EPS每股收益
USD 0.73
股本和储备
USD 2.54B
销售毛利
USD 864.4M
债务利息支出
USD 3.1M
利息收入
USD 16.9M
贷款资金
USD 1.3B
市值
USD 32.02B
净收入
USD 249.1M
营业费用
USD 990.1M
营业利润
USD 318.3M
普通股股本
USD 377.4M
PE价格收益
31.31
税前利润
USD 317.5M
销售收入
USD 1.34B
销售和管理费用
USD 358.7M
股票
USD 770.7M
贸易债权人
USD 2.08B
应收帐款人
USD 1.27B


Ebitda 更改 日
Abbott USD 2.43B 844M 2026-03
Align Technology USD 232.86M 3.72M 2026-06
AtriCure USD 26.8M 480K 2026-09
Baxter International USD 474M 165M 2026-06
Becton, Dickinson and Co. USD 1.71B 1B 2026-06
Boston Scientific USD 1.63B 27M 2026-06
Cooper Companies USD 67.9M 255.5M 2026-03
Dexcom USD 435.2M 46.5M 2026-09
Edwards Lifesciences USD 562.2M 6.6M 2026-06
Globus Medical USD 262.21M 17.63M 2026-09
Insulet USD 233.7M 33.9M 2026-09
Integra LifeSciences USD 79.79M 1.37M 2026-09
J&J USD 8.99B 721M 2026-06
Medtronic USD 2.63B 174M 2026-06
Merit Medical Systems USD 103.93M 461K 2026-09
Roche Holding CHF 13.43B 744M 2026-06
Solventum Corp USD 523M 147M 2026-09
Stryker USD 1.83B 102M 2026-09
Tandem Diabetes Care USD 18.04M 11.62M 2026-09
Teleflex USD 122.91M 47.28M 2026-06
West Pharmaceutical Services USD 267.4M 23.8M 2026-09
Zimmer Biomet Holdings USD 634.8M 195.7M 2026-09